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Abstract
Among mammals, there is a positive correlation between serum uric acid (UA) levels and life 
span. Humans have high levels of UA because they lack a functional urate oxidase (UOX) enzyme 
that is present in shorter lived mammals. Here, we show that male and female mice with UOX 
haploinsufficiency exhibit an age-related elevation of UA levels, and that the life span of female 
but not male UOX+/− mice is significantly increased compared to wild-type mice. Serum UA 
levels are elevated in response to treadmill exercise in UOX+/− mice, but not wild-type mice, and 
the endurance of the UOX+/− mice is significantly greater than wild-type mice. UOX+/− mice 
exhibit elevated levels of brain-derived neurotrophic factor, reduced brain damage and improved 
functional outcome in a model of focal ischemic stroke. Levels of oxidative protein nitration and 
lipid peroxidation are reduced in muscle and brain tissues of UOX+/− mice under conditions of 
metabolic and oxidative stress (running in the case of muscle and ischemia in the case of the 
brain), consistent with prior evidence that UA can scavenge peroxynitrite and hydroxyl radical. 
Our findings reveal roles for UA in life span determination, endurance and adaptive responses to 
brain injury, and suggest novel approaches for protecting cells against injury and for optimizing 
physical performance.
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1. Introduction
The Uox gene encoding the urate oxidase (UOX) protein is functional in rodents, but not in 
humans, as the result of multiple mutations that occurred in the UOX gene during the 
divergence of the living genera of hominoids (gibbons, orangutans, chimpanzees, gorillas, 
and humans) from the Old World monkeys (Friedman et al., 1985; Varela-Echavarria et al., 
1988; Wu et al., 1989). As a consequence, circulating uric acid (UA) levels in humans are 5–
10 times greater than rodents. UA is one of the most abundant antioxidant molecules in 
humans with a potent ability to scavenge peroxynitrite, nitric oxide, and hydroxyl radicals, 
thereby preventing protein nitration and lipid peroxidation (Hooper et al., 1997, 1998). 
Studies in animal models have shown that administration of UA or soluble UA analogs that 
retain the antioxidant properties of UA protects the brain against ischemic injury (Aliena-
Valero et al., 2018; Dhanesha et al., 2018; Haberman et al., 2007; Justicia et al., 2017; Yu et 
al., 1998), and a UA analog accelerates wound healing (Chigurupati et al., 2010), suggesting 
that UA can protect cells against injury and enhance repair of damaged tissue. The positive 
correlation between life span and UA levels among mammalian species suggests a potential 
role for UA in mitigating the aging process (Cutler, 1984). However, UA levels are elevated 
in gout and cardiovascular disease (Reginato et al., 2012; Zoppini et al., 2011) but are 
reduced in Parkinson’s disease and multiple sclerosis (Kutzing et al., 2008). The impact of 
endogenous UA in stroke is unclear (Dimitroula et al., 2008). Nevertheless, these findings 
from genetic, epidemiological, clinical, and experimental studies of UA suggest that 
concentrations of UA in the upper normal range are generally beneficial compared to lower 
concentrations, whereas higher concentrations that result in crystal formation are 
detrimental.
In response to physical exercise, levels of circulating and skeletal muscle UA increase in 
humans, as a result of ATP hydrolysis and inhibition of renal clearance of UA (Child et al., 
1998; Emmerson et al., 1978; Hellsten-Westing et al., 1994; Sutton et al., 1980). It has been 
proposed, but not established, that UA plays a role in sustaining muscle function and 
reducing cellular damage during intense physical exertion (Castejon et al., 2006; Green and 
Fraser, 1998). It is therefore conceivable that mutation of the Uox gene during primate 
evolution contributed to the superior endurance runner phenotype of humans (Mattson, 
2012). Targeted deletion of both Uox alleles in mice results in a more than 10-fold increase 
in UA levels and the development of nephrogenic diabetes insipidus and early death unless 
the mice are given allopurinol therapy (Kelly et al., 2001; Wu et al., 1994). However, we find 
that similar to humans (Gephardt et al., 1964; Kuzuya et al., 2002), circulating levels of UA 
increase in UOX+/− mice in an age-related manner and in response to stressful conditions, 
and that UOX+/− mice exhibit an extended life span, superior adaptive responses to stress 
that enhance physical endurance, and resistance of the brain to injury.
2. Materials and methods
2.1. Mice, UA analysis, and life span studies
Mice heterozygous for a disrupted Uox transgene (Wu et al.,1994) were obtained from 
Jackson Laboratories (Bar Harbor, ME) and were bred to generate the mice used in this 
study. The genetic background of the mice is C57BL/6J and 129Sv. Mice were maintained 
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according to National Institutes of Health guidelines on a standard diet with free access to 
water. To limit the levels of hyperuricemia, the UOX−/− mice in the longevity study received 
water supplemented with allopurinol (0.67 mM from birth to weaning, 0.18 mM for the first 
year, and 0.26 mM thereafter). Separate groups of mice were used for behavior, exercise, 
and stroke studies. Hyperuricemic conditions were obtained by terminating the allopurinol 
therapy 2 weeks before the beginning of the experiment. All procedures on animals were 
approved by the Animal Care and Use Committee of the National Institute on Aging 
Intramural Research Program. Blood was collected either by retro-orbital bleeding in live 
mice or by cardiac puncture at the time of euthanasia. Serum UA concentrations were 
measured using an assay kit (Randox, San Diego, CA) on a Roche Cobas Fara II robotic 
chemical analyzer according to the manufacturer’s specifications. DC-Cal and DC-Trol 
Level 1 and 2 Controls (Diagnostic Chemicals Limited, Oxford, CT) were used for 
instrument calibration and interassay accuracy, respectively.
2.2. Open field test
Open field testing was performed using the MEDOFA-MS system (Med Associated, St 
Albans, Vermont). Mice were placed in the center of the open field, and horizontal activity, 
stereotypical movements, and vertical activity were recorded for 15 minutes under dim light 
conditions. Spontaneous locomotor activity, stereotypical movements, and exploratory 
behavior were determined for each genotype.
2.3. Exercise studies
Mice were housed singly in Super Mouse Micro-Isolator cages (model 750; Lab Products 
Inc, Seaford, DE) with a wall-mounted 4.5 inch diameter Silent Spinner Wheel 
(PetSolutions, Beavercreek, OH) coupled to a bicycle odometer (Model BC506, Sigma Sport 
USA, Batavia, IL) with 2 neodymium magnets. Maximum speed, average speed, and total 
voluntary running distance were recorded twice weekly. For the training and exhaustion 
exercise model, mice were run on a treadmill (Model Exer-3/6 Treadmill, Columbus 
Instruments, Columbus, OH) at a 15° angle and 15 m/min speed for 1 hour daily or until 
exhaustion occurred. Exhaustion was reached when the animal fell off the treadmill 3 
consecutive times within a 10-second period.
2.4. Focal ischemic stroke
The methods for focal ischemia and reperfusion brain injury were identical to those reported 
previously (Arumugam et al., 2010). The middle cerebral artery was occluded for 1 hour 
using an intraluminal thread, and only mice with more than an 85% reduction in blood flow 
were included in the study. The functional deficit was evaluated at 24, 48, and 72 hours after 
stroke using a five-point rating scale (0, no deficit; 1, failure to extend left paw; 2, circling to 
the left; 3, falling to the left; 4, unable to the walk spontaneously). Mice were euthanized on 
poststroke day 3, and their brains were removed and coronal brain slices were stained with 
2% 2,3,5-triphenyltetrazolium chloride and evaluated for infarct size using standard 
methodology.
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2.5. Western blot analysis
Muscle and brain tissues were homogenized in RIPA buffer (20 mM Tris-HCl, 150 mM 
NaCl, 1 mM EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxycholate, 2.5 mM sodium 
pyrophosphate, and 1 mM sodium orthovanadate) containing protease inhibitors. The protein 
content of the samples was determined with Pierce BCA Protein Assay Kit (Pierce 
Biotechnology, Rockford, IL). Equal amounts of proteins were separated by sodium dodecyl 
sulfate polyacrylamide gel electrophoresis), and transferred onto nitro-cellulose membranes 
(Invitrogen, Hercules, CA). Membranes were incubated with a blocking buffer (5% dry milk 
in 20 mM Tris–HCl, pH 7.5, 500 mM NaCl, 0.05% Tween 20) for 1 hour at room 
temperature, then overnight with the primary antibody at 4 °C. Immunoreactive bands were 
detected using horse radish peroxidase-conjugated secondary antibody and a 
chemiluminescence kit from Pierce (Rockford, IL). The bands were analyzed by 
densitometry using the ImageJ analysis software (NIH). The following antibodies were used 
in this study: anti-β-actin (1:5000; Sigma); anti-3-nitrotyrosine (1:1000; Santa Cruz 
Biotechnology, Santa Cruz, CA, and Millipore, Billerica, MA).
2.6. Lipid analysis
Lipid extraction and analysis were performed as described previously (Cutler et al., 2004). 
Briefly, samples were injected using a Harvard Apparatus pump at 15 μL/min into an 
electrospray ionization (i.e., Turbo Ion Spray module) Sciex API 3000 triple stage 
quadrupole tandem mass spectrometer electrospray tandem mass spectrometry (ES/MS/MS) 
from Sciex Inc, Thornhill, Ontario, Canada, operating in the positive mode. The ion spray 
voltage (V) was 5500 at a temperature of 80 °C with a nebulizer gas of 8 psi, curtain gas of 8 
psi, and the collision gas set at 4 psi. The declustering potential was 80 V, focusing potential 
400 V, entrance potential −10 V, collision energy 30 V, and collision cell exit potential 18 V. 
The ES/MS/MS scanned from 300 to 2000 atomic mass units (amu) per second at a step of 
0.1 amu. Each lipid species was initially identified by a Q1 mass scan and then CAD gas 
breakdown products unique to each species were identified and used to make a standard 
curve. Samples were injected into the ES/MS/MS for 5 minutes, where the mass counts 
accumulated and the sum of the total counts under each peak were used to quantify each 
species. Positive identification and quantification of each species were achieved by precursor 
ion scanning or neutral loss scanning from a purified standard.
2.7. Statistical analysis
Survival curves were plotted using the Kaplan-Meier method, and log-rank Mantel-Cox and 
Wilcoxon tests were used to compare the curves. Results of both tests were comparable, and 
thus, only the results of the Mantel-Cox are reported. To assess the correlation between 
levels of UA and the different experiment variables, a Pearson correlation test was used. All 
the remaining statistical analyses were performed by either Student’s t-test or analysis of 
variance followed by post hoc test as appropriate. Analyses were performed using a Prism 
software package (GraphPad Software, San Diego, CA). Results are expressed as mean ± 
SEM. Values of p < 0.05 were considered statistically significant.
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3. Results
We measured circulating UA levels and life span in cohorts of UOX+/+, UOX+/−, and UOX 
−/− mice generated from crosses of heterozygous mice. The serum UA concentrations of 
young animals were (mg/dL) UOX+/+, 0.44 ± 0.05; UOX+/−, 0.54 ± 0.07; and UOX−/−, 4.4 
± 0.35 mg/dL (Fig. 1A). For the longevity study, to prevent kidney failure and early death, 
the UOX−/− mice were provided with allopurinol in their drinking water with the goal of 
maintaining UA levels within the normal range for humans. Although serum UA levels 
remained low during the life span of wild-type mice, UA increased by approximately 5-fold 
with age in UOX+/−mice (Fig. 1B). UA remained low in wild-type male and female mice 
throughout their life span, whereas UA levels increased with age in both male and female 
UOX+/− mice (Fig. 1C). Interestingly, male UOX−/− mice exhibited an age-related increase 
of UA levels, whereas the females did not (Fig. 1C). To determine whether UA levels might 
influence life span, we performed a survival study in male and female mice using each of the 
3 genotypes (Fig. 1D). Female UOX+/−mice lived significantly longer than female UOX−/− 
mice or female wild-type mice. In males, the life spans of UOX+/− and wild-type mice were 
similar, whereas UOX−/− male mice exhibited a significant reduction in life span (Fig. 1D). 
For UOX+/− mice, the changes in UA levels with age were very similar in the both genders 
(male r = 0.496 females r = 0.521), yet in the survival plots, it is clear that the female UOX+/
− mice live longer than wild-type females, but the male UOX+/− mice do not exhibit life 
span extension.
It has been proposed that UA plays an important role in animal foraging behavior (Johnson 
et al., 2009). Levels of UA increase during fasting conditions due to protein catabolism 
(Lennox, 1924), and this is associated with increased locomotor activity and decreased water 
excretion (Challet et al., 1995; Cherel and Le Maho, 1991). Moreover, UOX−/− mice with 
very high levels of UA display increased exploratory and novelty-seeking behavior 
compared to wild-type mice (Sutin et al., 2014). Further testing of all UOX genotypes in the 
open field confirmed that the overall distance covered by the UOX−/− mice in the arena was 
significantly greater than mice of the other 2 genotypes and was positively correlated with 
the levels of circulating UA (Fig. 2A). Furthermore, when mice were tested for an extended 
period of time in cages equipped with running wheels, we found significant positive 
correlations between UA levels and daily voluntary running distance in UOX+/− and UOX−/
− mice but not in UOX+/+ mice (Fig. 2B). Over a period of 5 months, young UOX−/− mice 
consistently ran further each day on the running wheel compared to wild-type mice (Fig. 
2C). By the end of the 5 month period, the UOX−/− mice ran 5 times further than the wild-
type mice as a result of the UOX−/− mice spending more time running, whereas their 
running speed was no different than the wild-type mice (Figs. 2C and D).
Brain-derived neurotrophic factor (BDNF) is produced by neurons in many brain regions 
where it plays critical roles in synaptic plasticity and resistance of neurons to stress (Mattson 
et al., 2004). In rodents, the expression of BDNF is increased in response to exercise in 
several brain regions including the hippocampus (Bekinschtein et al., 2011) and striatum 
(Marais et al., 2009), and BDNF can augment nigrostriatal dopaminergic signaling and loco-
motor behavior (Horger et al., 1999; Shen et al., 1994). We found that BDNF levels in the 
hippocampus were significantly higher in runner UOX−/− mice compared to runner UOX
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+/+ mice (Fig. 2E). There was a highly significant positive association of serum UA levels 
and hippocampal BDNF levels and a significant positive association of serum UA levels and 
average daily running distance (Fig. 2F). When we extended our analysis to sedentary UOX
−/− mice, we again found a significant positive correlation between the levels of 
hippocampal BDNF and serum UA (Fig. 2G) but not between levels of epidermal growth 
factor and UA (Fig. 2G), suggesting that UA may regulate the expression of BDNF in the 
brain.
Given the correlation between voluntary running and UA levels, we determined whether UA 
influences endurance. We first measured UA levels in sedentary mice and mice that had been 
subjected to strenuous treadmill exercise. Although treadmill running did not modify UA 
levels in UOX+/+ mice, it resulted in a two-fold increase in UA levels in UOX+/− mice (Fig. 
3A) and a 1.5-fold increase in UOX−/− mice (data not shown). We therefore performed a 
study involving 3 consecutive days of intense endurance running using UOX+/−, which 
showed an exercise-induced increase in UA similar to what has been reported in humans. 
The exercise-induced elevation of UA levels in UOX+/− mice was greater 6 hours after 
exercise in mice trained on a treadmill 1 hour daily for 3 consecutive days compared to UOX
+/− mice that were either run to exhaustion or trained for 3 days and then run to exhaustion 
(Fig. 3B), suggesting that UA may be partially consumed under conditions of intense muscle 
activity. We next evaluated the endurance of UOX+/+ and UOX+/− mice that had either been 
sedentary or trained for 3 days, by determining how long the mice could run until they were 
exhausted. Although 3 days of training did not modify the time to exhaustion in UOX+/+ 
mice, trained UOX+/− mice were able to run 5 times longer than nontrained UOX+/− mice 
(Fig. 3C). UA reacts with and neutralizes various reactive oxygen species in processes that 
result in degradation of UA (Kim et al., 2009). In response to vigorous exercise, protein 
tyrosine nitration, a modification resulting from the interaction of peroxynitrite with proteins 
(Souza et al., 2008), is increased in skeletal muscle cells (Vassilakopoulos et al., 2003). 
Because UA can scavenge peroxynitrite and can reduce protein nitration in experimental 
models of tissue injury (Hooper et al., 1998; Scott et al., 2005), we performed immunoblot 
analysis of nitrotyrosine in quadriceps muscle samples from UOX+/+ and UOX+/− mice 
collected at different intervals after treadmill running. Levels of nitrotyrosine were 
significantly increased in UOX+/+ mice after exercise but were not changed in the UOX+/− 
mice (Fig. 3D) although they ran significantly longer distances.
Because of their high metabolic rate and content of unsaturated fatty acids, neurons in the 
brain are particularly vulnerable to membrane lipid peroxidation (Scott and Hooper, 2001; 
Cutler et al., 2004). We chose to use the membrane lipid peroxidation product 4-
hydroxynonenal (HNE) as an indicator of oxidative damage for the experiment in Figure 4 
because it provides a measure complementary to 3-nitrotyrosine (3-NT). Indeed, previous 
studies have shown that UA can neutralize both peroxynitrite, which would be expected to 
reduce 3-NT levels, and hydroxyl radical, which would be expected to reduce membrane 
lipid peroxidation and HNE production (Becker, 1993; Cutler et al., 2015; Mattson et al., 
1997). We therefore tested the hypothesis that UA levels impact the vulnerability of brain 
cells by using UOX−/− mice deprived of allopurinol for 2 weeks, resulting in a broad range 
of UA levels among individual mice (Fig. 4A). Tandem mass spectrometry analysis of 
cerebral cortical tissue showed significantly lower levels of lipid peroxidation product HNE 
Cutler et al. Page 6
Neurobiol Aging. Author manuscript; available in PMC 2019 March 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
adducts in mice with higher levels of UA (Fig. 4B). Levels of HNE-lysine adducts were 
negatively correlated with the levels of UA (Fig. 4C) indicating that UA reduces basal levels 
of oxidative stress in the brain.
Stroke is a major cause of age-related morbidity and mortality. Treatment with exogenous 
UA or more soluble UA analogs can be beneficial in animal stroke models (Dhanesha et al., 
2018; Haberman et al., 2007; Romanos et al., 2007; Yu et al., 1998). However, in humans, 
both positive and negative associations between levels of UA and the outcome of ischemic 
stroke have been reported. We subjected UOX+/+ and UOX+/− mice to 1 hour of middle 
cerebral artery occlusion (MCAO) followed by reperfusion to mimic focal ischemic stroke. 
Although the initial functional deficit during the first 2 days after the stroke was similar in 
UOX+/+ and UOX+/− mice, the deficit on day 3 was significantly less in UOX+/− mice 
compared to UOX+/+ mice (Fig. 5A). After behavioral evaluation on poststroke day 3, mice 
were euthanized, and their brains were removed and processed for quantification of ischemic 
infarct size. The brain infarct volume of UOX+/− mice was significantly reduced compared 
to that of UOX+/+ mice (Fig. 5B). A second cohort of mice was euthanized 24 hours after 
sham surgery or MCAO to perform biochemical analyses of cortical brain tissue. In wild-
type mice, sham operation had no effect on brain UA levels, whereas MCAO caused a 
significant increase in cortical UA levels compared to control and sham-operated mice (Fig. 
5C), possibly as a result of increased purine catabolism from the damaged areas 
overpowering the ability of UOX to convert UA to allantoin. Interestingly, sham-operated 
UOX+/−mice showed a two-fold increase in levels of cortical UA compared to control UOX
+/− mice (Fig. 5C), whereas UA levels were reduced in the ischemic cortex of UOX+/− mice 
compared to control and sham-operated UOX+/− mice (Fig. 5C).
UA is nonenzymatically converted to other compounds when it interacts with and neutralizes 
free radicals (Becker, 1993), which could explain the reduction in UA levels in the ischemic 
brain tissue of UOX+/− mice. We tested this possibility by measuring the levels of allantoin, 
6-amino-uracil, triuret, and UA radical, which result from the interaction of UA with 
superoxide, nitric oxide, peroxynitrite, or other free radicals, respectively (Fig. 5D). 
Compared to sham wild-type mice, wild-type mice subjected to MCAO showed significantly 
decreased serum levels of allantoin and increased triuret levels (Fig. 5D). On the other hand, 
in UOX+/− mice subjected to MCAO, only the levels of the urate radical (Becker, 1993; 
Santus et al., 2001) were significantly elevated (Fig. 5D). Accordingly, a significant increase 
of oxidative/nitrosative damage was found in the cortex of MCAO UOX+/+ mice but not in 
UOX+/− mice (Fig. 5E).
4. Discussion
Our findings provide evidence that UA levels influence life span, increase rapidly in 
response to exercise stress, and increase the resistance of cells to oxidative damage and 
degeneration. UOX haploinsufficiency is one of only a few experimental genetic alterations 
shown to extend life span in mice, with mutations in insulin signaling-related genes also 
extending life span (Bartke et al., 2013). An enzyme-inactivating mutation(s) of the Uox 
gene was retained during primate evolution, resulting in positive correlation of UA levels 
with maximum life span, with humans having much higher UA levels than shorter-lived 
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primates and lower mammals (Ames et al., 1981; Cutler, 1984). Moreover, many birds have 
very high UA levels and longer life spans, despite relatively high metabolic rates (Klandorf 
et al., 2001). The fact that UOX−/− mice did not show an extension of life span is consistent 
with evidence that the loss of UOX activity in hominids was gradual and spanned millions of 
years, which likely allowed the parallel development of adaptive measures counteracting the 
detrimental effects of sudden hyper-uricemic conditions (Johnson et al., 2005).
Previous studies have shown that circulating levels of UA increase during and immediately 
after high-intensity endurance exercise. For example, high-intensity cycling increased 
plasma UA by 40%, and the UA levels remained elevated for at least 24 hours (Green and 
Fraser, 1988), and serum UA levels increase by 25% after high-intensity swimming in 
adolescents (Kabasakalis et al., 2014). Moreover, the fastest horses had significantly higher 
UA compared to the slower horses competing in endurance races (Castejon et al., 2006). It 
has been proposed, but not established, that UA plays a role in sustaining muscle function 
and reducing cellular damage during intense physical exertion (Castejon et al., 2006; Green 
and Fraser, 1998). Early interventional studies that attempted to relate UA levels to 
endurance in humans yielded mixed results. Williams et al. (1990) and Starling et al. (1996) 
administered the UA precursor inosine to runners and cyclists, respectively; inosines did not 
improve their performance. In the latter 2 studies, exercise increased UA levels, and inosine 
treatment did not increase UA levels in the runners but did increase UA levels in the cyclists. 
A second inosine supplementation trial in cyclists reported an increase in UA levels but no 
benefit on performance (McNaughton et al., 1999). All of these studies involved short-term 
inosine administration (2–11 days). It should also be noted that the athletes in these studies 
were already highly trained and so may therefore not have benefited from the inosine. 
Indeed, administration of UA intravenously to nonathletes immediately before 20 minutes of 
high-intensity aerobic exercise resulted in significantly lower levels of plasma markers of 
oxidative stress compared to subjects who received placebo (Waring et al., 2003).
We found that UOX-deficient mice with elevated UA levels exhibit a significant increase in 
the distance mice ran, both voluntarily on a running wheel in their home cage and when 
forced to run to exhaustion on a treadmill. Our findings suggest the possibility that elevated 
UA levels contribute to the endurance capacity of humans compared to nonhuman primates 
and lower mammals (Mattson, 2012). In a longitudinal study of older people, higher serum 
UA levels were associated with greater muscle strength measures in both men and women; 
the authors suggested that UA may protect muscle cells against age-related oxidative 
damage (Macchi et al., 2008). However, because exercise increases UA levels, the reported 
association between higher UA levels and better muscle function could be a selection bias 
that is merely separating people who routinely exercise versus those who do not. It should 
also be noted that excessively high UA levels are associated with poorer physical function 
and greater disabilities during aging, suggesting that there may be an optimal window of UA 
levels conducive to disease resistance and longevity (Ruggiero et al., 2007). Our findings 
support this notion, albeit with apparent gender differences in the UA levels that are optimal 
for longevity. Thus, we found that female UOX+/− mice with serum UA levels in the range 
of healthy humans exhibited a significant increase in life span, whereas male UOX+/− mice 
did not exhibit increased life span. On the other hand, although female UOX−/− mice with 
high UA levels lived as long as wild-type female mice, male UOX−/− mice had a shortened 
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life span. Based on the results of several necropsies, we believe that the main cause of 
shortened life span in the UOX−/−males was kidney damage caused by UA crystals. These 
findings in mice are of interest because in humans, women have lower blood UA than men 
(Anton et al., 1986).
Based on preclinical findings in rat and mouse stroke models (Haberman et al., 2007; Yu et 
al., 1998), clinical trials of UA in stroke patients were performed. Our results suggesting that 
an increase in the levels of endogenous UA in the early stages of stroke can be beneficial are 
supported by a phase II vehicle-controlled clinical trial of dual treatment with recombinant 
tissue plasminogen activator and UA within the first 3 hours of ischemic stroke onset 
(Amaro et al., 2007). Placebo-treated patients exhibited a 27% increase in levels of the lipid 
peroxidation product malondialdehyde 5 days after the infarct, whereas UA-treated patients 
had 30% lower levels of malondialdehyde. In a subsequent study, UA (1000 mg) was 
administered intravenously during a 90-minute period (in combination with thrombolytic 
therapy) within 5 hours of symptom onset (Chamorro et al., 2014). Patients in the UA group 
did not have a statistically significant improvement in outcome compared to those in the 
placebo group. Subsequent analysis of the data from the latter study revealed evidence that 
UA significantly improved outcome in women but not men (Llull et al., 2015) and that UA 
reduces early ischemic worsening after a stroke (Amaro et al., 2016). However, blood UA 
concentrations were not measured in this study and, therefore, the magnitude and duration of 
the UA elevation following administration is unknown. Efficacy might therefore be 
improved by administration of multiple doses of UA over a period of several days or more 
after stroke.
In addition to a potential therapeutic benefit in stroke, animal studies have shown that 
elevation of UA levels can ameliorate disease processes and improves functional outcome in 
models of multiple sclerosis and Parkinson’s disease (Chen et al., 2013; Duan et al., 2002; 
Hooper et al., 1998). Moreover, low UA levels are associated with an increased risk of 
Parkinson’s disease (Schwarzschild et al., 2011) and major depression (Bartoli et al., 2018). 
UA directly protects cultured neurons against degeneration induced by amyloid β peptide 
and iron by a mechanism involving reduction in protein nitration (Mattson et al., 1997). 
Oxidative stress and membrane lipid peroxidation contribute to the dysfunction and 
degeneration of neurons Alzheimer’s and Parkinson’s diseases and stroke (Mattson and 
Arumugam, 2018). The well-established anti-oxidant activity of UA is therefore a likely 
mechanism by which UA may retard aging and protects the brain against dysfunction and 
degeneration. However, we cannot rule out other potential mechanisms to explain the stress-
resistant phenotype of UOX-deficient mice. In this regard, we found that allantoin levels 
were reduced in brain tissue of UOX+/− mice and that UA radical levels were greatly 
elevated in UOX+/− mice after stroke. However, reduced allantoin levels are unlikely to 
explain the longevity and stress resistance of UOX+/− mice because supplementing the food 
of Caenorhabditis elegans with allantoin significantly extends life span (Calvert et al., 2016).
With regard to its effects on the healthy brain, the positive correlation between circulating 
UA levels and brain BDNF levels suggests that, in addition to its intrinsic antioxidant 
actions, UA may also benefit neurons by enhancing neurotrophic support. Indeed, BDNF is 
known to protect neurons against oxidative and metabolic stress and to enhance synaptic 
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plasticity and learning and memory (Greenberg et al., 2009; Mattson et al., 2004). In a 
longitudinal study of healthy adults, higher serum UA levels were associated with slower 
decline in visuospatial abilities and attention in men but not in women (Kueider et al., 2017). 
Previous studies demonstrated positive associations between blood UA levels and high 
energy/drive, positive affect, and achievement (Fowler, 1973; Lorenzi et al., 2010; Stevens et 
al., 1975). Therefore, although actions of UA on muscle cells could contribute to the 
enhanced endurance in UOX-deficient mice, it is also possible that UA might impact 
endurance by enhancing motivation and reducing psychological barriers that limit 
performance in endurance challenges.
Consistent with prior evidence that UA can scavenge peroxynitrite and hydroxyl radical 
(Haberman et al., 2007), we found that levels of oxidative protein nitration and lipid 
peroxidation are reduced in muscle and brain tissues of UOX+/− mice under conditions of 
metabolic and oxidative stress (running in the case of muscle and ischemia in the case of the 
brain). Although UOX+/−exhibited a complete suppression of cerebral ischemia-induced 
increase in brain 3-NT levels (and triuret levels) compared to UOX+/+ mice, the UOX+/− 
mice did not exhibit an elevation of muscle 3-NT levels under basal (no exercise) conditions. 
Although the antioxidant action of UA is therefore one explanation for enhanced endurance 
and longevity in mice with moderate elevation of UA levels, UA-independent mechanisms 
cannot be excluded. We were surprised that allantoin levels were reduced in brain tissue of 
UOX+/− mice, given that UA levels were elevated. On the other hand, an increase in UA 
radical levels after stroke would be expected to decrease allantoin levels, and we found that 
allantoin levels were indeed low after stroke (Fig. 5D). However, the possibility that reduced 
levels of allantoin mediate life span extension in UOX+/− mice is at odds with a recent 
report that supplementing the food of Caenorhabditis elegans with allantoin significantly 
extends life span (Calvert et al., 2016).
Our findings suggest that within the human physiological range of concentrations, UA can 
counteract the adverse effects of aging, strenuous exercise, and tissue damage in mice, 
thereby improving physical performance and resistance to metabolic and oxidative stress. If 
and to what extent the uricase-inactivating mutations that occurred during primate evolution 
contributed to the superior endurance, cognitive capabilities, and longevity of humans 
compared to lower primates and other mammals remains to be established. However, our 
findings in the present studies of UOX-deficient mice are consistent with such beneficial 
roles for UA on oxidative stress resistance and longevity.
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Fig. 1. 
Uricase haploinsufficiency results in age-dependent elevation of circulating uric acid levels 
and life span extension. (A) Serum levels of UA in wild-type (+/+; n = 41), heterozygous (+/
−; n = 10), and untreated (no allopurinol) homozygous (−/−; n = 40) UOX mice at 3 months 
of age (***p < 0.001). (B and C) The levels of UA were measured at the indicated times 
throughout the life span. No changes in the levels of serum UA were found in UOX+/+ 
mice, whereas a significant age-dependent, sex-independent increase of UA was observed in 
UOX+/− mice and in allopurinol-treated UOX−/− males (males +/+ n = 25, +/− n = 43, −/− 
n = 20; females +/+ n = 29, +/− n = 51, −/− n = 45); (D) Kaplan-Meier survival analysis of 
life span in mice of both genders (males +/+ n = 63, +/− n = 79, −/− n = 35; females +/+ n = 
86, +/− n = 43, −/− n = 48). In males, the survival curve of UOX−/− was significantly 
different from the UOX +/+ mice (Mantel-Cox log-rank test χ2 = 42.6). In females, the 
survival curve of UOX +/− was significantly different from UOX +/+ (Mantel-Cox-log-rank 
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test χ2 = 19.78). For these experiments, UOX−/− mice received allopurinol throughout their 
life. Abbreviations: UA, uric acid; UOX, urate oxidase.
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Fig. 2. 
Mice with elevated UA levels exhibit increased exploratory behavior, voluntary daily 
running distance, and brain BDNF levels. These experiments were performed using male 
mice. The UOX−/− mice received allopurinol for the duration of the study. (A) The total 
distance traveled in the open field arena was significantly greater in UOX−/− mice and 
positively correlated with the levels of circulating UA (7 mice per group; *p < 0.05 vs. +/+; 
##p < 0.01 vs. +/−). (B) Positive correlations between levels of UA and the average daily 
running distance (home cage running wheel) were observed for UOX+/− mice (n = 8) and 
UOX−/− mice (n = 11). (C and D) Over a period of 20 weeks, UOX−/− mice consistently 
ran further than UOX+/+ mice (C), whereas the initial difference in average speed was lost 
over time; (D) (6–10 mice per group; *p < 0.05, ***p < 0.001 vs. +/+; #p < 0.05, ###p < 
0.001 vs. the same genotype at week 1). (E and F) Mice were provided running wheels for a 
20 week period, and were euthanized in the morning between 8:00 and 12:00. (E) BDNF 
levels were significantly greater in the hippocampus of running UOX−/− mice compared to 
UOX+/+ mice (5–9 mice per group; **p < 0.01). (F) Levels of BDNF in the hippocampus of 
running mice were highly significantly correlated to the levels of UA and to a lower extent to 
the average daily traveled distance (5–9 mice per group). (G) Sedentary UOX−/− mice were 
deprived of allopurinol treatment for increasing lengths of time (from 0 to 2 weeks) to allow 
different degrees of hyperuricemia. Levels of BDNF and EGF were measured in the 
hippocampus; there was a significant positive association between levels of BDNF and UA 
(8–10 mice per group). Abbreviations: BDNF, Brain-derived neurotrophic factor; EGF, 
epidermal growth factor; UA, uric acid; UOX, urate oxidase.
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Fig. 3. 
Uricase haploinsufficiency results in increased levels of UA after intense exercise and 
improved running endurance. These experiments were performed using male mice. (A) UA 
levels were measured in sedentary mice and mice subjected to treadmill exercise. Exercise 
induced a significant upregulation of circulating levels of UA in UOX+/− mice (5 UOX+/+ 
mice and 14 UOX+/− mice; **p < 0.01 vs. sedentary mice). (B) Levels of UA were 
measured in UOX mice that were either run to exhaustion (Ex), trained for 3 days (T), or 
trained for 3 days and then run to exhaustion (T+Ex). Compared to sedentary mice (−), UA 
levels were increased by all types of exercise and were significantly higher in mice that were 
not run to exhaustion (3–5 mice per group; *p < 0.05, **p < 0.01, ***p < 0.001 vs. 
sedentary mice; ## p < 0.01 vs. Ex and T+EX mice). (C) Endurance was measured in UOX
+/+ and UOX+/− mice. (4 UOX+/+ and 5 UOX+/− mice); **p < 0.01 vs. sedentary UOX+/− 
mice). (D) Representative immunoblots and quantitation of 3-nitrotyrosine (3-NT) levels in 
quadriceps of sedentary mice (−) or mice subjected to either 1 day or 3 days of treadmill 
exercise. High levels of 3-NT were found in muscle of exercised UOX+/+ mice but not in 
exercised UOX+/− mice (3 mice per group; *p < 0.05, **p < 0.01 vs. UOX+/+ sedentary 
mice; #p < 0.05, ##p < 0.01 vs. corresponding exercised UOX+/− mice). Abbreviations: UA, 
uric acid; UOX, urate oxidase.
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Fig. 4. 
Uric acid decreases lipid peroxidation in the brain. (A) Male UOX−/− mice (6 months old) 
were deprived of allopurinol for 2 weeks to allow hyperuricemia. Based on the interanimal 
variability in levels of UA at the time they were euthanized, the mice were divided in 2 
groups, those with low and those with high UA levels (3 mice in the low-UA group and 8 
mice in the high-UA group; **p < 0.01). (B) Representative spectrograms showing the 
relative levels of HNE adducts in the cerebral cortex of mice with low or high levels of UA. 
(C) Negative correlation of UA levels with levels of HNE-lysine adducts. Abbreviations: 
HNE, 4-hydroxynonenal; UA, uric acid; UOX, urate oxidase.
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Fig. 5. 
Endogenous UA reduces protein nitration, is neuroprotective, and improves functional 
outcome in a mouse model of focal ischemic stroke. These experiments were performed 
using male mice. (A) Neurological deficit scores at the indicated time points after middle 
cerebral artery occlusion (MCAO) in male UOX+/+ and UOX+/− mice (6–10 mice per 
group; * p < 0.05). (B) Representative images of 2,3,5-triphenyltetrazolium chloride-stained 
brain sections and quantitation of the infarct volume 72 hours after MCAO (6–10 mice; *p < 
0.05). (C) Changes in cortical UA levels 24 hours after sham or MCAO surgery (5–6 mice; 
*p < 0.05; **p < 0.01 vs. UOX+/+ sham; ###p < 0.001 vs. UOX+/− sham; §§p < 0.01 vs. 
UOX+/+ MCAO). (D) Schematic of the UOX-mediated conversion of UA to allantoin, and 
nonenzymatic reactions of UA with superoxide (O2−), nitric oxide (NO), peroxynitrite 
(ONOO−), and other reactive oxygen species to generate the indicated products. The bottom 
panel shows the quantitative analysis for each of the oxidative UA derivatives in serum 
samples. (5–6 mice per group; *p < 0.05; **p < 0.01; ***p < 0.001 vs. UOX+/+ sham; ###p 
< 0.001 vs. UOX+/− sham; §p < 0.05, §§p < 0.01 §§§p < 0.001 vs. UOX+/+ MCAO). (E) 
Relative levels of 3-nitrotyrosine (3-NT) in the cortex of sham and MCAO mice 24 hours 
after surgery (5–6 mice per group; ***p < 0.001 vs. UOX+/+ sham; ###p < 0.001 vs. UOX
+/+ MCAO). Abbreviations: UA, uric acid; UOX, urate oxidase.
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